Abstract
Infections can be classified according to: (1) the type of offending microorganism (virus, bacteria, fungi, parasites), (2) according to the clearance by the defence system (T cell dependent/independent) and (3) in case bacteria are the causative agents in Gram-positive and Gram-negative infections. The latter classification in Gram-positive and Gram-negative infections has appeared to have a practical consequence. Gram-negative bacteria, often involved in major infections and yeasts, appear to play practically no role in the intestinal ecological system. Consequently, it is nowadays increasingly attempted to eliminate Gram-negative bacteria and yeasts selectively from the digestive tract with antimicrobial agents. Selective suppression of Gram-positive bacteria may severely affect the ecosystem of the digestive tract. This selective suppression of Gram-negatives must be continued as long as patients are immunocompromised (locally or systemically) and is called selective decontamination of the digestive tract.
Similar content being viewed by others
References
Elting LS, Bodey GP, Fainstein V (1986) Polymicrobial septicemia in the cancer patient. Medicine 65:218–225
Schimpff SC, Young V (1981) Epidemiology and prevention of infection in the compromised host. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host. Plenum Press, New York, pp 5–34
Shooter RA, Bettelheim KA, Lennox-King SMJ, O'Farrell S (1977)Escherichia coli serotypes in the faeces of healthy adults over a period of several months. J Hyg 78:95–98
Van der Waaij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JEC (1971) Colonization resistance of the digestive tract in conventional and antibiotic treated mice. J Hyg 69:405–411
Van der Waaij D, De Vries JM (1974) Determination of the colonization resistance of the digestive tract of individual mice. J Hyg 72:379–387
Van der Waaij D (1982) Colonization resistance of the digestive tract; clinical consequences and implications. J Antimicrob Chemother 10:263–270
Murray PR, Rosenblatt JE (1976) Bacterial interference by oropharyngeal and clinical isolates of anaerobic bacteria. J Infect Dis 134:281–285
Wilhelm MP, Lee DT, Rosenblatt JE (1987) Bacterial interference by anaerobic species isolated from human feces. Eur J Clin Microbiol 6:266–270
Van der Waaij D (1988) Evidence of immunoregulation of the composition of intestinal microflora and its practical consequences. Eur J Clin Microbiol Infect Dis 7:103–106
Tancrede CH, Andremont AO (1985) Bacterial translocation and Gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 152:99–103
Van der Waaij D (1984) Effect of antibiotics on colonization resistance. In: Easmon C, Jeljaszewics J (eds) Medical microbiology 4. Academic Press, London, pp 227–237
Veringa EM, Van der Waaij D (1983) Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract. J Antimicrob Chemother 14:605–612
Van der Waaij D (1985) Selective decontamination of the digestive tract with aztreonam and temocillin. Rev Infect Dis 7:S628-S633
Welling GW, Groen G, Welling-Wester S, De Vries-Hospers HG, Van der Waaij D (1987) Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers. Infection 15:188–191
Hofstra W, De Vries-Hospers HG, Van der Waaij D (1982) Concentrations of amphotericin B in faeces and blood of healthy volunteers after oral administration of various doses. Infection 10:223–227
De Vries-Hospers HG, Sleijfer DTh, Mulder NH, Van der Waaij D, Nieweg HO, Van Saene HKF (1981) Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients. Antimicrob Agents Chemother 19:812–830
Edlund C, Lindquist L, Nord CE (1988) Norfloxacin binds to human faecal material. Antimicrob Agents Chemother 32:1869–1874
Toorop-Bouma AG, Van der Waaij D (1987) Trimethoprim used for selective decontamination of the digestive tract in rats; possible route of excretion. Scand J Infect Dis 19:361–367
Van der Waaij D (1985) Selective decontamination of the digestive tract with oral aztreonam and temocillin. Rev Infect Dis [Suppl 4] 7:628–634
Rozenberg-Arska M, Dekker AW, Verhoef J (1983) Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukemia: decrease in emergence of resistant bacteria. Infection 11:167–169
Maschmeyer G, Haralambie E, Gaus W, Kern W, Dekker AW, De Vries-Hospers HG, Sizoo W, Konig W, Gutzler F, Daenen S (1988) Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection 16:98–104
Van der Waaij D, Tielemans-Speltie TM, De Rouck-Houben AMJ (1977) Infection by and distribution of biotypes of Enterobacteriaceae species in leukemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe. Infection 5:188–194
Dicke KA, Jagannath S, Spitzer G (1984) The role of autologous bone marrow transplantation in various malignancies. Ser Haematol 21:109–122
Santos GW, Yeager AM, Jones RJ (1989) Autologous bone marrow transplantation. Ann Rev Med 40:99–112
Thorp JM, Richards WC, Telfer ABM (1979) A survey of infection in an intensive care unit. Anaesthesia 34:643–650
Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR (1986) Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 133:792–796
Windsor JA, Hill GL (1988) Risk factors for postoperative pneumonia. The importance of protein depletion. Ann Surg 208:209–214
Kagan RJ, Matsuda T, Hanamaclass M, Jonasson O (1988) Serious wound infection in burned patients. Surgery 98:640–647
Ledingham IMcA, Alcock SR, Eastaway AT, McDonald JC, McKay IC, Ramsay G (1988) Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime and microbiological surveillance for infection prevention in intensive care. Lancet i:786–790
Manson WL, Westerveld AW, Klasen HJ, Sauer EW (1987) Selective intestinal decontamination of the digestive tract for infection prophylaxis in severely burned patients. Scand J Plast Reconstr Surg 21:269–272
Stoutenbeek CP, Van Saene HKF, Miranda DR, Zandstra DF (1984) The effect of selective decontamination of the digestive tract on colonization and infection rate of multiple trauma patients. Intensive Care Med 10:185–192
Kunin CM (1984) Genitourinary infections in the patient at risk: extrinsic risk factors. Am J Med 76:131–139
Pruitt BA, McManus AT (1984) Opportunistic infections in severly burned patients. Am J Med 76S:146–154
Pollack MM, Getson PR, Ruttimann UE, Steinhart CM, Kantor KK, Katz RW, Zucker AR, Glass NL, Spohn WA, Fuhrman BP, Wilkinson JD (1987) Efficiency of intensive care. A comparative analysis of eight pediatric intensive care units. JAMA 258:1481–1486
Brooks RG, Hofflin JM, Jamieson SW, Stinson EB, Remmington JS (1985) Infectious complications in heart-lung transplant recipients. Am J Med 79:412–422
Starzl TE, Koep LJ, Halgrimson CG (1979) Fifteen years of clinical liver transplantation. Gastroenterology 77:375–388
Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K, Noel D, Thomas ED (1979) Analysis of late infections in 89 longterm survivors of bone marrow transplantation. Blood 53:720–731
Bortin MM, Bale RP, Kay HEM, Rimm AA (1983) Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. JAMA 249:1166–1175
Schmeiser Th, Kurrle E, Arnold R, Krieger D, Heit W, Heimpel H (1988) Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation. Infection 16:19–24
Heimdahl A, Gahrton G, Groth CG, Lungren G, Lonnquist B, Ringden O, Nord CE (1984) Selective decontamination of the alimentary tract microbial flora in patients treated with bone marrow transplantation. A microbiological study. Scand J Infect Dis 16:51–60
Kusne S, Dummer JS, Singh N (1988) Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine 67:132–143
Slooff MJH, Rosman C, Van der Waaij D (1990) Selective decontamination of the digestive tract in hepatobiliary surgery; a concept. HBE Surg 2:1–5
Wiesner RH, Hermans PE, Rakela J, Washington JA, Perkins JD, DiCecio S, Krom RAF (1988) Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 45:570–574
Sleÿfer DTh, Mulder NH, De Vries-Hospers HG, Fidler V, Nieweg HO, Van der Waaij D, Van Saene HKF (1980) Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 16:859–869
Hargadon MT, Young VM, Schimpff C, Wade JC, Minah GA (1981) Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia. Antimicrob Agents Chemother 20:620–625
Bow EJ, Louie TJ, Riben PD, Harding GKM, Ronald AR (1984) Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients. Am J Med 76:223–233
Henry SA (1984) Chemoprophylaxis of bacterial infections in granulocytopenic patients. Am J Med 76:645–651
Kurrle E, Dekker AW, Gaus W, Haralambie E, Krieger DG, Rozenberg-Arska M, De Vries-Hospers HG, Van der Waaij D (1986) Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. Infection 14:226–232
Hughes WT, Kuhn S, Chaudhury S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL (1977) Successful chemoprophylaxis forPneumocystis carinii pneumonitis. N Engl J Med 297:1419–1426
De Vries-Hospers HG, Van der Waaij D (1980) Salivary concentrations of amphotericin B following its use as an oral lozenge. Infection 8:63–65
De Vries-Hospers HG, Van der Waaij D (1978) Amphoterine B concentrations in saliva after application of 2% amphotericin B in orabase. Infection 1:16–20
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Waaij, D., Manson, W.L., Arends, J.P. et al. Clinical use of selective decontamination: The concept. Intensive Care Med 16 (Suppl 3), S212–S216 (1990). https://doi.org/10.1007/BF01709703
Issue Date:
DOI: https://doi.org/10.1007/BF01709703